| References | Journal | Year | |
MK-2206, an allosteric Akt inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular targeted drugs in vitro and in vivo.
Hirai, H., Sootome, H., Nakatsuru, Y., Miyama, K., Taguchi, S., Tsujioka, K., Ueno, Y., Hatch, H., Majumder, P.K., Pan, B.S., Kotani, H. | Mol Cancer Ther. | 2010 | View |
MMP-2 and MMP-9 are elevated in spinal cord and skin in a mouse model of ALS.
Fang, L., Teuchert, M., Huber-Abel, F., Schattauer, D., Hendrich, C., Dorst, J., Zettlmeissel, H., Wlaschek, M., Scharffetter-Kochanek, K., Kapfer, T., Tumani, H., Ludolph, A.C., Brettschneider, J. | J Neurol Sci. | 2010 | View |
Modeling asthma in macaques: longitudinal changes in cellular and molecular markers.
Ayanoglu, G., Desai, B., Fick, R.B. Jr., Grein, J., de Waal Malefyt, R., Mattson, J., McClanahan, T., Olmstead, S., Reece, S.P., Van Scott, M.R., Wardle, R.L. | Eur Respir J. | 2010 | View |
Modeling familial Danish dementia in mice supports the concept of the amyloid hypothesis of Alzheimer's disease.
Coomaraswamy, J., Kilger, E., Wölfing, H., Schäfer, C., Kaeser, S.A., Wegenast-Braun, B.M., Hefendehl, J.K., Wolburg, H., Mazzella, M., Ghiso, J., Goedert, M., Akiyama, H., Garcia-Sierra, F., Wolfer, D.P., Mathews, P.M., Jucker, M. | Proc Natl Acad Sci USA. | 2010 | View |
Modulation of gamma-secretase reduces beta-amyloid deposition in a transgenic mouse model of Alzheimer's disease.
Kounnas, M.Z., Danks, A.M., Cheng, S., Tyree, C., Ackerman, E,, Zhang, X., Ahn, K., Nguyen, P., Comer, D., Mao, L., Yu, C., Pleynet, D., Digregorio, P.J., Velicelebi, G., Stauderman, K.A., Comer, W.T., Mobley, W.C., Li, Y.M., Sisodia, S.S., Tanzi, R.E., Wagner, S.L. | Neuron. | 2010 | View |
Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial.
Carbonell-Estrany, X., Simões, E.A., Dagan, R., Hall, C.B., Harris, B., Hultquist, M., Connor, E.M., Losonsky, G.A.; Motavizumab Study Group. | Pediatrics | 2010 | View |
mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophy.
Song, X., Kusakari, Y., Xiao, C.Y., Kinsella, S.D., Rosenberg, M.A., Scherrer-Crosbie, M., Hara, K., Rosenzweig, A., Matsui, T. | Am J Physiol Cell Physiol. | 2010 | View |
Mumps and ovarian cancer: modern interpretation of an historic association.
Cramer, D.W., Vitonis, A.F., Pinheiro, S.P., McKolanis, J.R., Fichorova, R.N., Brown, K.E., Hatchette, T.F., Finn, O.J. | Cancer Causes Control. | 2010 | View |
Natural innate cytokine response to immunomodulators and adjuvants in human precision-cut lung slices.
Switalla, S., Lauenstein, L., Prenzler, F., Knothe, S., Forster, C., Fieguth, H.G., Pfennig, O., Schaumann, F., Martin, C., Guzman, C.A., Ebensen, T., Muller, M., Hohlfeld, J.M., Krug, N., Braun, A., Sewald, K. | Toxicol Appl Pharmacol. | 2010 | View |
Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism.
Mattsson, N., Bremell, D., Anckarsater, R., Blennow, K., Anckarsater, H., Zetterberg, H., Hagberg, L. | BMC Neurol. | 2010 | View |
No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects.
Jorde, R., Sneve, M., Torjesen, P.A., Figenschau, Y., Gøransson, L.G., Omdal, R. | Cytokine | 2010 | View |
No increases in biomarkers of genetic damage or pathological changes in heart and brain tissues in male rats administered methylphenidate hydrochloride (Ritalin) for 28 days.
Witt, K.L., Malarkey, D.E., Hobbs, C.A., Davis, J.P., Kissling, G.E., Caspary, W., Travlos, G., Recio, L. | Environ Mol Mutagen. | 2010 | View |
Novel insights into the cellular mechanisms of the anti-inflammatory effects of NF-kB essential modulator (NEMO) binding domain peptides.
Baima, E.T., Guzova, J.A., Mathialagan, S., Nagiec, E.E., Hardy, M.M., Song, L.R., Bonar, S.L., Weinberg, R.A., Selness, S.R., Woodard, S.S., Chrencik, J., Hood, W.F., Schindler, J.F., Kishore, N., Mbalaviele, G. | J Biol Chem. | 2010 | View |
Novel pharmacological MC4R agonists can efficiently activate mutated-MC4R from obese patients with impaired endogenous agonist response.
Roubert, P., Dubern, B., Plas, P., Lubrano-Berthelier, C., Alihi, R., Auger, F., Deoliveira, D.B., Dong, J.Z., Basdevant, A., Thurieau, C., Clement, K. | J Endocrinol. | 2010 | View |
Omega-3 fatty acid supplementation improves vascular function and reduces inflammation in obese adolescents.
Dangardt, F., Osika, W., Chen, Y., Nilsson, U., Gan, L.M., Gronowitz, E., Strandvik, B., Friberg, P. | Atherosclerosis. | 2010 | View |
Omega-3 fatty acid supplements in women at high risk of breast cancer have dose-dependent effects on breast adipose tissue fatty acid composition.
Yee, L.D., Lester, J.L., Cole, R.M., Richardson, J.R., Hsu, J.C., Li, Y., Lehman, A., Belury, M.A., Clinton, S.K. | Am J Clin Nutr. | 2010 | View |
Orally administered bifidobacteria as vehicles for delivery of agents to systemic tumors.
Cronin, M., Morrissey, D., Rajendran, S., El Mashad, S.M., van Sinderen, D., O'Sullivan, G.C., Tangney, M. | Mol Ther. | 2010 | View |
Osteopontin Is Required for the Early Onset of High Fat Diet-Induced Insulin Resistance in Mice.
Chapman, J., Miles, P.D., Ofrecio, J.M., Neels, J.G., Yu, J.G., Resnik, J.L., Wilkes, J., Talukdar, S., Thapar, D., Johnson, K., Sears, D.D. | PLoS ONE | 2010 | View |
Osteopontin mediates Citrobacter rodentium-induced colonic epithelial cell hyperplasia and attaching-effacing lesions.
Wine, E., Shen-Tu, G., Gareau, M.G., Goldberg, H.A., Licht, C., Ngan, B.Y., Sorensen, E.S., Greenaway, J., Sodek, J., Zohar, R., Sherman, P.M. | Am J Pathol. | 2010 | View |
Pharmacology and placental transfer of a human av integrin monoclonal antibody in rabbits.
Martin, P. L., Zhou, Z., Van den Bulck, K., Kwok, D., Powers, G., Jiao, Q., Schantz, A., Treacy, G. | Birth Defects Res B Dev Reprod Toxicol. | 2010 | View |
Phase 1 study of AMG 386, a selective angiopoietin 1/2-neutralizing peptibody, in combination with chemotherapy in adults with advanced solid tumors.
Mita, A.C., Takimoto, C.H., Mita, M., Tolcher, A., Sankhala, K., Sarantopoulos, J., Valdivieso, M., Wood, L., Rasmussen, E., Sun, Y.N., Zhong, Z.D., Bass, M.B., Le, N., LoRusso, P. | Clinical Cancer Research | 2010 | View |
Phase 1 study of the investigational, oral angiogenesis inhibitor motesanib in Japanese patients with advanced solid tumors.
Fujisaka, Y., Yamada, Y., Yamamoto, N., Shimizu, T., Fujiwara, Y., Yamada, K., Tamura, T., Watanabe, H., Sun, Y.N., Bass, M.B., Seki, M. | Cancer Chemother Pharmacol. | 2010 | View |
Phase I and Pharmacokinetic Study of CT-322 (BMS-844203), a Targeted Adnectin Inhibitor of VEGFR-2 Based on a Domain of Human Fibronectin.
Tolcher, A.W., Sweeney, CJ., Papadopoulos, K., Patnaik, A., Chiorean, E.G., Mita, A.C., Sankhala, K., Furfine, E., Gokemeijer, J., Iacono, L., Eaton, C., Silver, B.A., Mita, M. | Clin Cancer Res. | 2010 | View |
Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma.
Batchelor, T.T., Duda, D.G., di Tomaso, E., Ancukiewicz, M., Plotkin, S.R., Gerstner, E., Eichler, A.F., Drappatz, J., Hochberg, F.H., Benner, T., Louis, D.N., Cohen, K.S., Chea, H., Exarhopoulos, A., Loeffler, J.S., Moses, M.A., Ivy, P., Sorensen, A.G., Wen, P.Y., Jain, R.K. | J Clin Oncol. | 2010 | View |
Phase II Study of Neoadjuvant Bevacizumab and Radiotherapy for Resectable Soft Tissue Sarcomas.
Yoon, S.S., Duda, D.G., Karl, D.L., Kim, T.M., Kambadakone, A.R., Chen, Y.L., Rothrock, C., Rosenberg, A.E., Nielsen, G.P., Kirsch, D.G., Choy, E., Harmon, D.C., Hornicek, F.J., Dreyfuss, J., Ancukiewicz, M., Sahani, D.V., Park, P.J., Jain, R.K., Delaney, T.F. | Int J Radiat Oncol Biol Phys. | 2010 | View |